Rx Injury Claims May Grow After Court Finds Brand Liable For Generic Problems
Executive Summary
The pharmaceutical industry is reeling from a court ruling that found brand name manufacturers are liable for the warnings on generic versions of their products
You may also be interested in...
Brand-Name Drug Makers' Duty To Warn Extends After Product Sale To Another Company
California Supreme Court finds Novartis liable for alleged injuries from use of a generic version of Brethine even though they occurred six years after Novartis transferred the NDA; dissenting opinion says this will expose companies to "liability in perpetuity."
Brand-Name Drug Makers' Duty To Warn Extends After Product Sale To Another Company
California Supreme Court finds Novartis liable for alleged injuries from use of a generic version of Brethine even though they occurred six years after Novartis transferred the NDA; dissenting opinion says this will expose companies to "liability in perpetuity."
FDA Generic Labeling Rule Could Help Pfizer In Reglan Product Liability Suit
Alabama Supreme Court is reconsidering its decision holding brand-name manufacturers liable for injuries caused by generics; Pfizer argues that FDA’s forthcoming proposed rule would eliminate concerns that no company could be held liable for injuries from a generic.